Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05877599
Title A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Neogene Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
University of California, Los Angeles (UCLA) RECRUITING Los Angeles California 90095 United States Details
Hoag Medical Group RECRUITING Newport Beach California 92663 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Rutgers University RECRUITING New Brunswick New Jersey 09803 United States Details
Providence Cancer Institute RECRUITING Portland Oregon 97225 United States Details
Sarah Cannon Research Institute (SCRI) Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Baylor Scott & White Medical Center RECRUITING Dallas Texas 75246 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field